Oncology PracticeExciting advances in HR-positive breast cancer: Top five picks from SABCSDecember 16, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeBreast conservation safe option in multisite breast cancerDecember 15, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeCTC-guided therapy beats physician choice in metastatic breast cancerDecember 15, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeWomen can safely interrupt endocrine therapy to pursue pregnancyDecember 15, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeKey research on TNBC: Top five picks from SABCSDecember 15, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeTerminally ill cancer patients struggle to access psilocybinDecember 14, 2022Patient & Survivor CareMetastatic Breast Cancer
Oncology PracticeCapivasertib/fulvestrant improves progression free survival in breast cancerDecember 14, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeGene signature may spare some breast cancer patients from radiationDecember 14, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeHigh response rates with T-DXd in early HER2-low breast cancerDecember 12, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeOral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancerDecember 9, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeChemotherapy meets its match against aggressive ER+/HER2– breast cancersDecember 9, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticePotential cause of worse outcomes among Black breast cancer patients foundDecember 9, 2022Breast CancerMetastatic Breast Cancer
Oncology PracticeDiagnosed too lateDecember 6, 2022Patient & Survivor CareRenal Cell CarcinomaPreventive CarePractice ManagementMixed TopicsMetastatic Breast CancerMelanoma
Oncology PracticeManaging trastuzumab deruxtecan adverse events in the real worldDecember 1, 2022Metastatic Breast CancerBreast Cancer
Oncology PracticeWhole breast radiation for breast cancer shown to be safe and effectiveDecember 1, 2022Metastatic Breast CancerBreast Cancer
